phosphotyrosine has been researched along with thrombin receptor peptide sfllrnp in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auberger, P; Belhacene, N; Far, DF; Imbert, V; Mari, B; Peyron, JF; Pouysségur, J; Rossi, B; Van Obberghen-Schilling, E | 1 |
1 other study(ies) available for phosphotyrosine and thrombin receptor peptide sfllrnp
| Article | Year |
|---|---|
Thrombin and thrombin receptor agonist peptide induce early events of T cell activation and synergize with TCR cross-linking for CD69 expression and interleukin 2 production.
Topics: Amino Acid Sequence; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Base Sequence; Binding Sites; Calcium; Cell Line; Consensus Sequence; Humans; Interleukin-2; Kinetics; Lectins, C-Type; Lymphocyte Activation; Molecular Sequence Data; NF-kappa B; Oligodeoxyribonucleotides; Peptide Fragments; Phosphoproteins; Phosphotyrosine; Protein Kinase C; Receptors, Antigen, T-Cell; Receptors, Cell Surface; Receptors, Thrombin; RNA, Messenger; T-Lymphocytes; Thrombin; Tumor Cells, Cultured; Tyrosine | 1994 |